SQSTM1 and malignant colon neoplasm: Through proteomic and GO analyses, we found that the upregulated proteins p62 and LC3B in the autophagy pathway were enriched after CAPE treatment, indicating that CAPE may exert its drug-sensitizing effects by regulating autophagy in colon cancer cells.